Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Brooklyn, New York 11219


Purpose:

The proposed prospective study aims to determine whether interpretation of PSA levels in morbidly obese men require correction due to the obesity itself. If PSA levels are found to rise after weight loss, interpretation of PSA levels in morbidly obese men may be improved by upward correction of the PSA level. A 'correction factor' may be proposed for the interpretation of PSA levels in obese men, toward the clinical decision regarding indication for prostate biopsy.


Study summary:

The main objective of this study is to determine whether interpretation of PSA levels in morbidly obese men require correction due to the obesity itself. Secondary outcome measures that will be followed include the affect of obesity and weight loss on testosterone, estradiol and leptin. In as much as these might also affect PSA, we will be measuring these values as well. Also, we do not know the effects of lap-band induced weight loss on clinical outcome measures of sexual, bowel and urinary function. Thus we will aim to investigate these parameters as well.


Criteria:

Inclusion Criteria: - obese men undergoing lap-band surgey Exclusion Criteria: - prior diagnosis of prostate cancer, prior prostate surgery, use of 5-alpha reductase inhibitors and history prostatitsis or recurrent UTI.


NCT ID:

NCT00562341


Primary Contact:

Principal Investigator
Jason Wynberg, MD
MMC


Backup Contact:

N/A


Location Contact:

Brooklyn, New York 11219
United States

Jason Wynberg
Email: jwynberg@maimonidesmed.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: August 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.